1,259 results match your criteria: "Hair Graft Transplantation for Baldness"
J Craniofac Surg
December 2024
Department of Dermatological Surgery, Shenyang Seventh People's Hospital, Shenyang, Liaoning, China.
Background And Rationale: Scarring alopecia significantly impacts patients' appearance and psychological well-being. Surgery is a common cause of scarring alopecia, making positive treatment crucial for patients' overall health.
Objective: To investigate the clinical efficacy of autologous follicular unit extraction (FUE) transplantation for postoperative secondary stable scarring alopecia and evaluate its effectiveness.
Ann Dermatol
December 2024
Department of Dermatology, College of Medicine, Dankook University, Cheonan, Korea.
Background: Hair transplantation (HT) has been reported to be effective for the treatment of female-pattern hair loss (FPHL). Few studies have investigated HT in FPHL.
Objective: To evaluate the clinical features of FPHL treated with HT and analyze the real-world results of HT.
J Ayub Med Coll Abbottabad
November 2024
Department of Burns & Plastic Surgery, University College of Medical Sciences and G.T.B. Hospital, Delhi-India.
Plastic surgeons face unique challenges in reconstructing eyebrows due to their complex anatomy and gender variations. We report a case of a 16-year-old female who presented with post-burn bilateral eyebrow alopecia. Bilateral eyebrow reconstruction was performed with scalp island flaps based on the posterior branch of the superficial temporal artery, which showed good postoperative outcomes.
View Article and Find Full Text PDFStem Cell Res Ther
November 2024
State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Druggability of Biopharmaceuticals, School of Life Science and Technology, China Pharmaceutical University, Nanjing, 210009, China.
Background: The use of mesenchymal stem cells (MSCs) is recognized as a promising strategy for the treatment of androgenetic alopecia (AGA). However, the underlying mechanism remains to be explored. Here, we evaluated the therapeutic effects and potential mechanisms of the use of human umbilical cord mesenchymal stem cells (hUCMSCs) in dihydrotestosterone (DHT)-induced AGA models in vivo and in vitro.
View Article and Find Full Text PDFJ Cosmet Dermatol
November 2024
Department of Plastic and Reconstructive Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, People's Republic of China.
Background: Androgenetic alopecia (AGA) is the most prevalent type of hair loss. Traditionally, treatment for AGA has primarily involved the topical application of minoxidil in conjunction with oral finasteride or spironolactone. Recently, platelet-rich plasma (PRP) has emerged as a significant focus of research in hair loss treatment.
View Article and Find Full Text PDFBMC Surg
November 2024
Department of Plastic and Burn Surgery and Medical Cosmetic Surgery, The First Affiliated Hospital of Xi'an Medical University, Xi'an Shaanxi, 710077, P.R. China.
Exp Dermatol
October 2024
Translational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar.
Actas Dermosifiliogr
October 2024
Dermatology Department, Trichology Unit, Ramon y Cajal University Hospital, University of Alcala, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, España; Trichology and Hair Transplantation Unit, Grupo Pedro Jaen Clinic, Madrid, España.
J Cosmet Dermatol
December 2024
Department of Dermatology, Shanghai Institute of Dermatology, Huashan Hospital, Fudan University, Shanghai, P.R. China.
Background: The robotic hair transplant technology, ARTAS, has a series of fine mechanical structure and an intelligent recognition system that allows it to independently select hair follicular units (FUs) and effectively harvest hair. After entering China in 2016, ARTAS has attracted the attention of hair transplant surgeons and hair loss patients given its advantages in a short learning curve and simple operation.
Objective: To compare the efficacy and safety between the ARTAS system and follicular unit excision (FUE) in the treatment of male androgenetic alopecia (AGA) and to further promote the improvement and upgrading of ARTAS technology concerning hair transplantation.
Noncoding RNA Res
February 2025
Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Fayoum University, Fayoum, 63514, Egypt.
J Med Life
June 2024
Department of Plastic and Reconstructive Surgery, Bagdasar-Arseni Emergency Hospital, Bucharest, Romania.
Int J Nurs Stud Adv
December 2024
Department of Plastic Surgery, The First People's Hospital, 310000, Address :No.261, Huansha Road, Hangzhou, Zhejiang, China.
Int J Mol Sci
August 2024
Department of Dermatology, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 03312, Republic of Korea.
Dermatol Ther (Heidelb)
October 2024
Pfizer Inc, New York, NY, USA.
J Eur Acad Dermatol Venereol
September 2024
Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico S. Orsola-Malpighi, Bologna, Italy.
Background: Alopecia areata is an autoimmune condition characterized by rapid hair loss in the scalp, eyebrows and eyelashes, for which treatments are limited. Baricitinib, an oral inhibitor of Janus kinases 1 and 2, has been recently approved to treat alopecia areata.
Materials And Methods: We conducted a retrospective study involving 23 medical centres across Italy, enrolling patients affected by severe alopecia areata (SALT >50), for more than 6 months.
Aesthetic Plast Surg
August 2024
Department of Otolaryngology-Head and Neck Surgery, Division of Facial Plastic and Reconstructive Surgery, Harvard Medical School, Massachusetts Eye and Ear, 243 Charles Street, Boston, MA, 02114, USA.
Aesthetic Plast Surg
October 2024
Department of Plastic, Reconstructive and Aesthetic Surgery, Biruni University Medical Faculty, Istanbul, Turkey.
J Cosmet Dermatol
December 2024
Division in Anatomy and Developmental Biology, Department of Oral Biology, Human Identification Research Institute, BK21 FOUR Project, Yonsei University College of Dentistry, Seoul, South Korea.
Skin Appendage Disord
August 2024
Department of Dermatologic Surgery, Dermatology Institute Prof. Rubem David Azulay (IDPRDA), Santa Casa da Misericórdia, Rio de Janeiro, Brazil.
Introduction: Cicatricial alopecia (CA) poses a challenge for dermatologists due to irreversible hair follicle damage. While pharmacological treatments offer limited efficacy, surgical interventions aim to improve aesthetic outcomes. This article explores the serial excision technique (SET) as a viable option for stable cases of inflammatory CA.
View Article and Find Full Text PDFCurr Protoc
August 2024
Department of Dermatology and Skin Science, University of British Columbia, Vancouver, British Columbia, Canada.
Alopecia areata is the second most common form of hair loss in humans after androgenetic alopecia. Although a variety of animal models for alopecia areata have been described, currently the C3H/HeJ mouse model is the most commonly used and accepted. Spontaneous hair loss occurs in 15%-25% of older mice in which the lesions wax and wane, similar to the human disease, with alopecia being more common and severe in female mice.
View Article and Find Full Text PDFJ Plast Reconstr Aesthet Surg
September 2024
Department of Plastic and Aesthetic Surgery, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China. Electronic address:
Ann Chir Plast Esthet
November 2024
Centre médico-chirurgical du cuir chevelu, 23, avenue Niel, 75017 Paris, France. Electronic address:
The eyebrow is an aesthetic unit playing an important role in the balance and expression of the face. It consists of hairs whose different orientations make its complexity. The main causes of eyebrow alopecia are repeated eyebrow plucking, reduced density due to age, and post-traumatic alopecia.
View Article and Find Full Text PDFClin Cosmet Investig Dermatol
July 2024
Department of Dermatology, Venereology and Cosmetology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, People's Republic of China.
Purpose: Alopecia significantly affects the appearance and psychology of patients, and pharmacological therapies and hair transplantation are the main treatments for alopecia, but both have limitations. This review aimed to summarize the non-pharmacological therapies that promote hair growth and regeneration.
Patients And Methods: This is a non-systematic review.
J Eur Acad Dermatol Venereol
August 2024
Hair Disorders Unit, Dermatology Department, Ramon y Cajal Hospital, IRYCIS, University of Alcala, Madrid, Spain.
Actas Dermosifiliogr
July 2024
Dermatology Department, Trichology Unit, Ramon y Cajal University Hospital, University of Alcala, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain; Trichology and Hair Transplantation Unit, Grupo Pedro Jaen Clinic, Madrid, Spain.